We are live on ! Find out more
SIC

Salem Investment Counselors Portfolio holdings

AUM $4.03B
1-Year Est. Return 61.49%
This Fund
S&P 500
This Quarter Est. Return
-3.42%
1 Year Est. Return
+61.49%
3 Year Est. Return
+158.64%
5 Year Est. Return
+203.54%
10 Year Est. Return
+1,118.52%
AUM
$2.87B
AUM Growth
-$178M
Cap. Flow
-$36.1M
Cap. Flow %
-1.26%
Top 10 Hldgs %
47.06%
Holding
1,269
New
65
Increased
259
Reduced
220
Closed
49

Top Sells

Rank Stock Value
1
PLTR icon
Palantir
PLTR
+$15.7M
2
MU icon
Micron Technology
MU
+$7.87M
3
LOW icon
Lowe's Companies
LOW
+$7.83M
4
TTE icon
TotalEnergies
TTE
+$5.87M
5
AAPL icon
Apple
AAPL
+$4.15M

Sector Composition

Rank Sector Weight
1 Technology 27.5%
2 Consumer Discretionary 20.06%
3 Financials 11.37%
4 Healthcare 10.34%
5 Communication Services 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EOG icon
376
EOG Resources
EOG
$74.2B
$174K 0.01%
1,353
+58
+4% +$7.46K
PAYX icon
377
Paychex
PAYX
$43.6B
$173K 0.01%
1,121
QIPT
378
DELISTED
Quipt Home Medical
QIPT
$172K 0.01%
74,000
MET icon
379
MetLife
MET
$61.7B
$172K 0.01%
2,139
-213
-9% -$17.7K
AMAT icon
380
Applied Materials
AMAT
$441B
$163K 0.01%
1,125
+50
+5% +$8.41K
BIV icon
381
Vanguard Intermediate-Term Bond ETF
BIV
$28.9B
$162K 0.01%
2,115
-167
-7% -$12.6K
IJJ icon
382
iShares S&P Mid-Cap 400 Value ETF
IJJ
$9.06B
$162K 0.01%
1,352
XITK icon
383
State Street SPDR FactSet Innovative Technology ETF
XITK
$72.5M
$160K 0.01%
999
-5
-0.5% -$893
CLX icon
384
Clorox
CLX
$12.7B
$158K 0.01%
1,070
+45
+4% +$6.87K
AVUS icon
385
Avantis US Equity ETF
AVUS
$14.4B
$156K 0.01%
1,686
VRTX icon
386
Vertex Pharmaceuticals
VRTX
$131B
$155K 0.01%
320
+61
+24% +$28.4K
SNAP icon
387
Snap
SNAP
$8.88B
$155K 0.01%
17,800
-2,005
-10% -$20.9K
SUN icon
388
Sunoco
SUN
$14.1B
$155K 0.01%
2,666
VLO icon
389
Valero Energy
VLO
$97.9B
$155K 0.01%
1,172
+43
+4% +$5.71K
MCO icon
390
Moody's
MCO
$83.5B
$149K 0.01%
321
+9
+3% +$4.34K
DHR icon
391
Danaher
DHR
$143B
$147K 0.01%
715
-5
-0.7% -$1.09K
GM icon
392
General Motors
GM
$75.8B
$146K 0.01%
3,115
-550
-15% -$27.1K
DWSN icon
393
Dawson Geophysical
DWSN
$138M
$144K 0.01%
116,800
-1,869
-2% -$2.6K
RSG icon
394
Republic Services
RSG
$66B
$142K 0.01%
587
+387
+194% +$86.8K
VTWO icon
395
Vanguard Russell 2000 ETF
VTWO
$17.5B
$141K ﹤0.01%
1,750
IAU icon
396
iShares Gold Trust
IAU
$64.6B
$140K ﹤0.01%
2,371
-604
-20% -$32.7K
SCHG icon
397
Schwab US Large-Cap Growth ETF
SCHG
$63.1B
$139K ﹤0.01%
5,546
+59
+1% +$1.62K
MDT icon
398
Medtronic
MDT
$116B
$138K ﹤0.01%
1,525
+422
+38% +$37.8K
VEU icon
399
Vanguard FTSE All-World ex-US ETF
VEU
$70.7B
$138K ﹤0.01%
2,268
-2,000
-47% -$121K
ZTS icon
400
Zoetis
ZTS
$30.7B
$136K ﹤0.01%
824

Similar funds

Salem Investment Counselors's Q1 2025 Portfolio in Review

As of Q1 2025, Salem Investment Counselors held 1,269 positions worth $2.87B, down 5.8% from $3.05B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Salem Investment Counselors's Q1 2025 filing shows 65 new, 259 increased, 220 reduced and 49 closed positions. Its largest new stake was Hims & Hers Health: 265,468 shares worth $7.84M. The largest sale was Palantir, an estimated $15.7M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Salem Investment Counselors's largest Q1 2025 buy was Hims & Hers Health: 265,468 shares worth $7.84M.
  • Salem Investment Counselors added most to Advanced Micro Devices in Q1 2025, an estimated $9.87M increase.
  • Salem Investment Counselors's biggest Q1 2025 reduction was Palantir, cutting an estimated $15.7M.
  • Salem Investment Counselors fully exited MaxCyte in Q1 2025, selling an estimated $235K.
  • Salem Investment Counselors's ten largest holdings make up 47% of its $2.87B portfolio in Q1 2025.
  • Salem Investment Counselors opened 65 new positions and closed 49 in Q1 2025.
  • Salem Investment Counselors's portfolio value fell 5.8% quarter-over-quarter to $2.87B.

Based on Salem Investment Counselors's 13F filing for Q1 2025, filed 16 Apr 2025.